1 |
Holmgren L, O'Reilly MS, Folkman J : Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1 : 149, 1995
DOI
|
2 |
Sheng H, Shao J, Morrow JD et al : Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58 : 362, 1998
PUBMED
|
3 |
Chan TA, Morin PJ, Vogelstein B et al : Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95 : 681, 1998
DOI
|
4 |
DuBois RN, Shao J, Tsujii M et al : G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 56 : 733, 1996
PUBMED
|
5 |
Gilroy D, Saunders M, Wu K : COX-2 expression and cell cycle progression in human fibroblasts. Am J Physiol Cell Physiol 281 : C188, 2001
DOI
|
6 |
Moore RJ, Zweifel BS, Heuvelman DM et al : Enhanced antitumor activity co-administration of celecoxib and the chemotherapeutic agents cyclophosphamide and 5-fu. Proceedings of the American Association for Cancer Research: 1-5 April Cadmus Journal Services, Linthicum, MD USA Abstract 2600, 2000, p.409
|
7 |
Kishi K, Petersen S, Petersen C et al : Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 60 : 1326, 2000
PUBMED
|
8 |
Reed DW, Bradshaw WS, Xie W et al : In vivo and in vitro expression of a non-mammalian cyclooxygenase-1. Prostaglandins 52 : 269, 1996
DOI
ScienceOn
|
9 |
Hanif R, Pittas A, Feng Y et al : Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52 : 237, 1996
DOI
ScienceOn
|
10 |
Bright-Thomas RM, Hargest R : APC, beta-Catenin and hTCF-4: An unholy trinity in the genesis of colorectal cancer. Eur J Surg Oncol 29 : 107, 2003
DOI
ScienceOn
|
11 |
Form DM, Auerbach R : PGE2 and angiogenesis. Proc Soc Exp Biol Med 172 : 214, 1983
DOI
PUBMED
|
12 |
Lang S, Lauffer L, Clausen C et al : Impaired monocyte function in cancer patients: Restoration with a cyclooxygenase-2 inhibitor. FASEB J 17 : 286, 2003
DOI
PUBMED
|
13 |
Sonoshita M, Takaku K, Sasaki N et al : Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC (716) knockout mice. Nat Med 7 : 1048, 2001
DOI
ScienceOn
|
14 |
Yip-Schneider MT, Sweeney CJ, Jung SH et al : Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther 298 : 976, 2001
PUBMED
|
15 |
Dannenberg AJ, DuBois RN(eds) : COX-2: A New Target for Cancer Prevention and Treatment. New York, NY, Karger, 2003, p.52
|
16 |
Herschman HR : Primary response genes induced by growth factors and tumor promoters. Ann Rev Biochem 60 : 281, 1991
DOI
ScienceOn
|
17 |
Dannenberg AJ, Altorki NK, Boyle JO et al : Cyclo-oxygenase 2: A pharmacological target for the prevention of cancer. Lancet Oncol 2 : 544, 2001
DOI
ScienceOn
|
18 |
Jabbour H, Milne S, Williams A et al : Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer 85 : 1023, 2001
DOI
PUBMED
ScienceOn
|
19 |
Gilroy D, Saunders M, Sansores-Garcia L et al : Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts. FASEB J 15 : 288, 2001
DOI
PUBMED
|
20 |
Mork J : Forty years of monitoring head and neck cancer in Norway?no good news. Anticancer Res 18 : 3705, 1998
PUBMED
|
21 |
Waddell WR, Ganser GF, Cerise EJ et al : Sulindac for polyposis of the colon. Am J Surg 157 : 175, 1989
DOI
ScienceOn
|
22 |
Parkin DM : Global cancer statistics in the year 2000. Lancet Oncol 2 : 533, 2001
DOI
ScienceOn
|
23 |
Williams CW, DuBois RN : Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270 : G393, 1996
|
24 |
Waddell WR, Loughry RW : Sulindac for polyposis of the colon. J Surg Oncol 24 : 83, 1983
DOI
ScienceOn
|
25 |
Kawamori T, Rao CV, Seibert K et al : Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58 : 409, 1998
PUBMED
|
26 |
Kundu N, Smyth MJ, Samsel L et al : Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle. Breast Cancer Res Treat 76 : 57. 2002
DOI
ScienceOn
|
27 |
DuBois RN, Abramson SB, Crofford L et al : Cyclooxygenase in biology and disease. FASEB J 12 : 1063, 1998
DOI
PUBMED
|
28 |
Scioscia KA, Snyderman CH, Rueger R et al : Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal anti-inflammatory drugs. Am J Otol 18 : 1, 1997
DOI
ScienceOn
|
29 |
Masferrer JL, Zweifel BS, Manning PT et al : Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91 : 3228, 1994
DOI
ScienceOn
|
30 |
Kelly DJ, Mestre JR, Subramaniak K et al : Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 18 : 795, 1997
DOI
ScienceOn
|
31 |
Harris RE, Alshafie GA, Abou-Issa H et al : Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 60 : 2101, 2000
PUBMED
|
32 |
Boolbol SK, Dannenberg AJ, Chadburn A et al : Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56 : 2556, 1996
PUBMED
|
33 |
Forastiere A, Koch W, Trotti A et al : Head and neck cancer. N Engl J Med 345 : 1890, 2001
DOI
ScienceOn
|
34 |
Oshima M, Dinchuk JE, Kargman SL et al : Suppression of intestinal polyposis in Apc716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 : 803, 1996
DOI
ScienceOn
|
35 |
Furuta Y, Hall ER, Sanduja S et al : Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res 48 : 3002, 1988
PUBMED
|
36 |
Ziche M, Jones J, Gullino PM : Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 69 : 475, 1982
PUBMED
|
37 |
Chan G, Boyle JO, Yang EK et al : Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59 : 991, 1999
PUBMED
|
38 |
Simon LS : Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheum 8 : 169, 1996
DOI
ScienceOn
|
39 |
Brown JR, DuBois RN : COX-2: A molecular target for colorectal cancer prevention. J Clin Oncol 23 : 2840, 2005
DOI
ScienceOn
|
40 |
Tsujii M, DuBois RN : Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83 : 705, 1995
|
41 |
Cutler NS, Graves-Deal R, LaFleur BJ et al : Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res 63 : 1748, 2003
PUBMED
|
42 |
Toyoshima T, Kamijo R, Takizawa K et al : Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21. Br J Cancer 86 : 1150, 2002
DOI
ScienceOn
|
43 |
Lippman SM, Hong WK : Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17 : 691, 1989
DOI
PUBMED
ScienceOn
|
44 |
Goodwin JS, Ceuppens J : Regulation of the immune response by prostaglandins. J Clin Immunol 3 : 295, 1983
DOI
|
45 |
El Attar TM, Lin HS : Prostaglandin synthesis by squamous carcinoma cells of head and neck, and its inhibition by non-steroidal anti-inflammtory drugs. J Oral Pathol 16 : 483, 1987
DOI
|
46 |
Barnes CJ, Lee M : Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology 114 : 873, 1998
DOI
ScienceOn
|
47 |
Nathans D, Lau LF, Christy B et al : Genomic response to growth factors. Cold Spring Harbor Symp Quant Biol 53 : 893, 1998
|
48 |
Eling TE, Thompson DC, Foureman GL et al : Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol 30 : 1, 1990
DOI
PUBMED
ScienceOn
|
49 |
Hong SH, Ondtey FG, Avis IM et al : Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J 14 : 1449, 2000
|
50 |
Smalley WE, DuBois RN : Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol 39 : 1, 1997
DOI
|
51 |
Reed JC : Fenretinide: the death of a tumor cell. J Natl Cancer Inst 91 : 1099, 1999
DOI
|
52 |
Thun MJ, Henley SJ, Patrono C : Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst (Bethesda) 94 : 252, 2002
DOI
ScienceOn
|